Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
The Journal of Clinical Endocrinology and Metabolism|January 7, 2005
Vitamin d deficiency and seasonal variation in an adult South Florida populationSilvina Levis, Angela Gomez, Camilo Jimenez, et al.Plos One|June 4, 2010
Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26Mary A Fletcher, Xiao R Zeng, Kevin Maher, et al.Head & Neck|November 1, 2007
Unequal burden of head and neck cancer in the United StatesW Jarrard Goodwin, Giovana R Thomas, Dorothy F Parker, et al.The Science of Diabetes Self-Management and Care|August 2, 2025
Lack of Association of Emotional Distress With Insulin Initiation in the GRADE Randomized Diabetes Comparative Effectiveness TrialCaroline A Presley, Nicole M Butera, Heidi Krause-Steinrauf, et al.Journal of the American Geriatrics Society|April 12, 2002
Alendronate reduces the risk of multiple symptomatic fractures: results from the fracture intervention trialSilvina Levis, Sara A Quandt, Desmond Thompson, et al.Diabetes Care|September 27, 2023
The Use of Rescue Insulin in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)Priscilla A Hollander, Heidi Krause-Steinrauf, Nicole M Butera, et al.Behavioral and Brain Functions : BBF|December 31, 2010
Plasma neuropeptide Y: a biomarker for symptom severity in chronic fatigue syndromeMary A Fletcher, Martin Rosenthal, Michael Antoni, et al.Menopause (New York, N.Y.)|July 16, 2008
Earlier age at menopause, work, and tobacco smoke exposureLora E Fleming, Silvina Levis, William G LeBlanc, et al.The Journal of Clinical Endocrinology and Metabolism|June 6, 2003
Autosomal dominant hyperostosis/osteosclerosis with high serum alkaline phosphatase activityCarlos Hernandez-Cassis, Claudia K Vogel, Tatiana P Hernandez, et al.Oncotarget|March 3, 2016
Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailtySamuel Golpanian, Darcy L DiFede, Marietsy V Pujol, et al.Pageof 5